Literature DB >> 11981817

Alternative end joining during switch recombination in patients with ataxia-telangiectasia.

Qiang Pan1, Corinne Petit-Frére, Aleksi Lähdesmäki, Hanna Gregorek, Krystyna H Chrzanowska, Lennart Hammarström.   

Abstract

Ataxia-Telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic diseases with similar cellular phenotypes that are caused by mutations in the recently described ATM (encoding ATM) and NBS1 (encoding p95) genes, respectively. Both disorders are accompanied by immunodeficiency in a majority of patients, but the mechanism involved has as yet not been established. We demonstrate that in cells from A-T patients, the switch (S) recombination junctions are aberrant and characterized by a strong dependence on short sequence homologies and devoid of normally occurring mutations around the breakpoint. A low number of S fragments were generated in cells from NBS patients and showed only limited dependence on sequence identity and mutation frequencies were similar to those observed in normal controls. We propose that ATM and p95 are both involved in the final step(s) in class switch recombination with related, but disparate, functional roles. Thus, the general pathway involved in DNA repair also has a major influence on the immunoglobulin isotype switching process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11981817     DOI: 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation.

Authors:  Xiaoping Wu; Connie Y Tsai; Marienida B Patam; Hong Zan; Jessica P Chen; Steve M Lipkin; Paolo Casali
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

2.  DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions.

Authors:  Rohit A Panchakshari; Xuefei Zhang; Vipul Kumar; Zhou Du; Pei-Chi Wei; Jennifer Kao; Junchao Dong; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

3.  Activation-induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase.

Authors:  Muneer G Hasham; Kathy J Snow; Nina M Donghia; Jane A Branca; Mark D Lessard; Janet Stavnezer; Lindsay S Shopland; Kevin D Mills
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

4.  DCLRE1C (ARTEMIS) mutations causing phenotypes ranging from atypical severe combined immunodeficiency to mere antibody deficiency.

Authors:  Timo Volk; Ulrich Pannicke; Ismail Reisli; Alla Bulashevska; Julia Ritter; Andrea Björkman; Alejandro A Schäffer; Manfred Fliegauf; Esra H Sayar; Ulrich Salzer; Paul Fisch; Dietmar Pfeifer; Michela Di Virgilio; Hongzhi Cao; Fang Yang; Karin Zimmermann; Sevgi Keles; Zafer Caliskaner; S Ükrü Güner; Detlev Schindler; Lennart Hammarström; Marta Rizzi; Michael Hummel; Qiang Pan-Hammarström; Klaus Schwarz; Bodo Grimbacher
Journal:  Hum Mol Genet       Date:  2015-10-16       Impact factor: 6.150

5.  SHLD2 promotes class switch recombination by preventing inactivating deletions within the Igh locus.

Authors:  Alexanda K Ling; Meagan Munro; Natasha Chaudhary; Conglei Li; Maribel Berru; Brendan Wu; Daniel Durocher; Alberto Martin
Journal:  EMBO Rep       Date:  2020-06-17       Impact factor: 8.807

6.  Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.

Authors:  Maria B Almejun; Montserrat Cols; Marta Zelazko; Matias Oleastro; Andrea Cerutti; Pablo Oppezzo; Charlotte Cunningham-Rundles; Silvia Danielian
Journal:  Eur J Immunol       Date:  2013-01-18       Impact factor: 5.532

7.  Novel antibody switching defects in human patients.

Authors:  John P Manis; Frederick W Alt
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan.

Authors:  Tomohiro Morio; Naomi Takahashi; Fumiaki Watanabe; Fumiko Honda; Masaki Sato; Masatoshi Takagi; Ken-Ichi Imadome; Toshio Miyawaki; Domenico Delia; Kotoka Nakamura; Richard A Gatti; Shuki Mizutani
Journal:  Int J Hematol       Date:  2009-08-25       Impact factor: 2.490

Review 10.  Non-homologous end joining in class switch recombination: the beginning of the end.

Authors:  Ashwin Kotnis; Likun Du; Chonghai Liu; Sergey W Popov; Qiang Pan-Hammarström
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-03-12       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.